- Home
- FATE vs LGI Comparison
FATE vs LGI Comparison
Compare FATE & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FATE | LGI |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.0M | 242.7M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | FATE | LGI |
|---|---|---|
| Price | $1.29 | $16.59 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $5.72 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 56.6K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.10% |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,646,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.72 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.95 | $15.32 |
| 52 Week High | $3.23 | $19.88 |
Technical Indicators
Market Signals| Indicator | FATE | LGI |
|---|---|---|
| Relative Strength Index (RSI) | 23.18 | 47.30 |
| Support Level | $1.07 | $16.20 |
| Resistance Level | $1.38 | $16.85 |
| Average True Range (ATR) | 0.16 | 0.23 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 7.35 | 47.45 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About LGI Lazard Global Total Return and Income Fund
Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.